V. Aaltonen et al., Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro, AM J PATH, 154(3), 1999, pp. 755-765
Citations number
55
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
The NF1 gene product (neurofibromin) is known to act as a tumor suppressor
protein by inactivating ms. The best documented factors involved in urinary
bladder transitional cell carcinoma (TCC) are ras proto-oncogene activatio
n and p53 suppressor gene mutations. This Is the first study reporting alte
rations In NF1 gene expression in TCC. We examined NF1 gene expression in a
total of 29 surgical urinary bladder TCC specimens representing grades 1 t
o 3 and in three cell lines, RT4, 5637, and T24 (representing grades 1 to 3
, respectively). Decreased NF1 gene expression was observed in 23 of 29 (83
%) TCC specimens as estimated by immunohistochemistry the decrease being mo
re pronounced in high-grade tumors. NF1 mRNA levels were markedly lower in
TCC tissue compared with adjacent non-neoplastic urothelium, as studied by
in situ hybridization for grade 3 TCC. Immunohistochemistry and Western blo
tting demonstrated that TCC cell lines expressed NF1 protein at different l
evels, expression being almost undetectable in T24 (grade 3) cells. Norther
n blotting for cell lines demonstrated reduced NF1 mRNA levels in grade 3 T
CC cells. Reverse transcription polymerase chain reaction for cell lines an
d selected grade 2 and grade 3 tissue samples demonstrated NF1 type II mRNA
isoform predominance in all samples studied. Our results show that both NF
1 mRNA and protein levels are decreased in high-grade TCC, suggesting that
alterations of NF1 gem expression may be involved In. bladder TCC carcinoge
nesis.